up-regulated |
|
|
|
GO: 0007049 |
cell cycle |
89 |
9.94E-16 |
GO: 0000278 |
mitotic cell cycle |
57 |
1.48E-15 |
GO: 0000280 |
nuclear division |
43 |
1.70E-15 |
GO: 0007067 |
mitosis |
43 |
1.70E-15 |
GO: 0000087 |
M phase of mitotic cell cycle |
43 |
3.32E-15 |
GO: 0022403 |
cell cycle phase |
60 |
4.19E-15 |
GO: 0006955 |
immune response |
81 |
6.99E-15 |
GO: 0048285 |
organelle fission |
43 |
7.36E-15 |
GO: 0000279 |
M phase |
51 |
4.60E-14 |
GO: 0022402 |
cell cycle process |
70 |
4.79E-14 |
KEGG: hsa04640 |
Hematopoietic cell lineage |
18 |
5.94E-06 |
KEGG: hsa04110 |
Cell cycle |
19 |
2.61E-04 |
KEGG: hsa05332 |
Graft-versus-host disease |
9 |
0.001447 |
KEGG: hsa04612 |
Antigen processing and presentation |
13 |
0.002663 |
KEGG: hsa04666 |
Fc gamma R-mediated phagocytosis |
13 |
0.008088 |
KEGG: hsa04662 |
B cell receptor signaling pathway |
11 |
0.01045 |
KEGG: hsa05322 |
Systemic lupus erythematosus |
13 |
0.011134 |
KEGG: hsa04620 |
Toll-like receptor signaling pathway |
13 |
0.012956 |
KEGG: hsa04060 |
Cytokine-cytokine receptor interaction |
25 |
0.015748 |
KEGG: hsa04650 |
Natural killer cell mediated cytotoxicity |
15 |
0.020645 |